Suchergebnisse - "Spiekermann, Karsten"

PubPharm (235)

31

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2023

von Berdel, A. | Koch, R. | Gerss, J. | +15

32

AGIHO guideline on evidence-based management of COVID-19 in cancer patients : 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

enthalten in: European journal of cancer | 16 January 2023

von Giesen, N. | Busch, E. | Schalk, E. | +24

33

Allogeneic hematopoietic cell transplantation vs standard consolidation chemotherapy in patients with intermediate-risk acute myeloid leukemia : a randomized clinical trial: original investigation

enthalten in: JAMA oncology | February 9, 2023

von Bornhäuser, M. | Schliemann, C. | Schetelig, J. | +26

34

Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis

enthalten in: Cancer | 2022

von Pastore, F. | Pastore, A. | Rothenberg-Thurley, M. | +12

35

Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Hoffmeister-Wittmann, P. | Mock, A. | Nichetti, F. | +45

36

Compartment-specific mutational landscape of clonal hematopoiesis

enthalten in: Leukemia | 2022

von Hartmann, L. | Hecker, J. | Rothenberg-Thurley, M. | +24

37

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2022

von Berdel, A. | Koch, R. | Gerss, J. | +15

38

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

enthalten in: Annals of hematology | 2022

von Berdel, A. | Koch, R. | Gerss, J. | +15

39

Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration

enthalten in: bioRxiv.org | 2022

von Nicolai, L. | Leunig, A. | Pekayvaz, K. | +13

40

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: Infection | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9